Page 1 of Clinical Trials for Drug Sargramostim, 752 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Completed
A Study to Compare the Effectiveness of a Four Drug Anti-HIV Regimen Given Alone or in Combination With GM-CSF or IL-12 to HIV-Positive Patients
Last Updated: May 16, 2012
Condition(s): HIV Infections
2
Completed
Phase I Trial of mBACOD and Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in AIDS-Associated Large Cell, Immunoblastic, and Small Non-cleaved Lymphoma
Last Updated: April 26, 2012
Condition(s): Lymphoma, Non-Hodgkin; HIV Infections
3
Completed
A Phase I Study of the Combination of Recombinant GM-CSF, AZT, and Chemotherapy (ABV) (Adriamycin, Bleomycin, Vincristine) in AIDS and Kaposi's Sarcoma
Last Updated: April 26, 2012
Condition(s): Sarcoma, Kaposi; HIV Infections
4
Completed
The Safety and Effectiveness of Ganciclovir Used Alone or in Combination With Granulocyte-Macrophage Colony Stimulating Factor in the Treatment of Cytomegalovirus (CMV) of the Eye in Patients With AIDS
Last Updated: April 26, 2012
Condition(s): Cytomegalovirus Retinitis; HIV Infections
5
Completed
A Phase I Trial of Recombinant Human Granulocyte-Macrophage Colony Stimulating Factor (rHuGM-CSF), Recombinant Alpha Interferon and Azidothymidine (AZT) in AIDS-Associated Kaposi's Sarcoma
Last Updated: May 22, 2012
Condition(s): Sarcoma, Kaposi; HIV Infections
6
Recruiting
Plerixafor and Sargramostim (GM-CSF) for Mobilization of Allogeneic Sibling Donors
Last Updated: November 2, 2011
Condition(s): Leukemia, Myeloid, Acute; Myelodysplastic Syndromes; Lymphoma, Non-Hodgkin; Hodgkin Disease; Leukemia, Lymphocytic, Chronic, B-Cell; Multiple Myeloma
7
Completed
Granulocyte-Macrophage Colony-Stimulating Factor and Zidovudine: A Phase I Study of Concurrent Administration in Patients With AIDS and Severe ARC
Last Updated: April 25, 2012
Condition(s): HIV Infections; Cytopenias
8
Completed
The Effectiveness of GM-CSF in HIV-Positive Patients Who Are Also Receiving Anti-HIV Therapy
Last Updated: May 16, 2012
Condition(s): HIV Infections
9
Completed
A Phase I/II Pilot Study of Simultaneously Administered Rhu GM-CSF ( CHO Cell ) and Azidothymidine ( AZT ) in Patients With Severe HIV Infection and Leukopenia: Pharmacokinetics and Feasibility
Last Updated: June 23, 2005
Condition(s): HIV Infections; Cytopenias
10
Active, not recruiting
IMA910 Plus GM-CSF With Low-dose Cyclophosphamide Pre-treatment in Advanced Colorectal Carcinoma Patients Following a Successful 12 Week First-line Treatment With Oxaliplatin-based Chemotherapy (IMA910-101)
Last Updated: February 1, 2012
Condition(s): Colorectal Carcinoma
11
Completed
Daunorubicin & Cytarabine +/- Zosuquidar inTreating Older Patients With Newly Diagnosed Acute Myeloid Leukemia or Refractory Anemia
Last Updated: June 21, 2011
Condition(s): Leukemia; Myelodysplastic Syndromes
12
Completed
Phase II GM-CSF Plus Mitoxantrone in Hormone Refractory Prostate Cancer
Last Updated: September 10, 2010
Condition(s): Prostatic Neoplasms
13
Terminated
CHOP-Rituximab Augmented With GM-CSF in Patients With Previously Untreated Diffuse Large B Cell Non-Hodgkin's Lymphoma
Last Updated: July 19, 2011
Condition(s): Lymphoma, Non-Hodgkin; Lymphoma, B-Cell; Lymphoma, Diffuse
14
Active, not recruiting
Phase II Study of Fludarabine and Mitoxantrone, Followed by GM-CSF and Rituximab
Last Updated: June 21, 2011
Condition(s): Lymphoma
15
Completed
A Phase III Randomized Trial of Low-Dose Versus Standard-Dose mBACOD Chemotherapy With rGM-CSF for Treatment of AIDS-Associated Non-Hodgkin's Lymphoma
Last Updated: April 26, 2012
Condition(s): Lymphoma, Non-Hodgkin; HIV Infections
16
Active, not recruiting
Topotecan Plus Sargramostim in Treating Patients With Advanced Cancer
Last Updated: February 6, 2009
Condition(s): Unspecified Adult Solid Tumor, Protocol Specific
17
Active, not recruiting
Combination Chemotherapy Plus Amifostine in Treating Patients With Advanced Cancer
Last Updated: February 19, 2012
Condition(s): Chronic Myeloproliferative Disorders; Drug/Agent Toxicity by Tissue/Organ; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Precancerous Condition; Unspecified Adult Solid Tumor, Protocol Specific
18
Active, not recruiting
Laboratory-Treated Autologous Lymphocytes, Aldesleukin, and Sargramostim (GM-CSF) in Treating Patients With Advanced Solid Tumors
Last Updated: September 20, 2011
Condition(s): Neoplasms; Tumors; Solid Tumors; Metastatic Cancer
19
Active, not recruiting
Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Refractory Hodgkin's Disease or Non-Hodgkin's Lymphoma
Last Updated: February 6, 2009
Condition(s): Lymphoma
20
Active, not recruiting
Docetaxel and Vinorelbine Plus Sargramostim in Metastatic Malignant Melanoma
Last Updated: August 15, 2011
Condition(s): Metastatic Melanoma

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Drug+Sargramostim

Page 1 of Clinical Trials for Drug Sargramostim, 752 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About